REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sinhagad Pharma Private Limited (India)

Main Activities: Other Chemical Product and Preparation Manufacturing
Full name: Sinhagad Pharma Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Sinhagad Pharma Private Limited is an unlisted company, incorporated on 17/08/2020. It has its registered office in the State of PN, India. Company's corporate identification number (CIN) is U24290PN2020PTC193023 and registration number is 193023. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Fl 03 H No 211 Manogandh Shilp Opp Kedar App
Pune; Maharashtra; Postal Code: 411051

Contact Details: Purchase the Sinhagad Pharma Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Sinhagad Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Sinhagad Pharma Private Limited report to view the information.
Incorporation Date:
August 17, 2020
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Sinhagad Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
16.32%▲
Total operating revenue
16.33%▲
Operating profit (EBIT)
-30.2%▼
EBITDA
-28.45%▼
Net Profit (Loss) for the Period
-42.11%▼
Total assets
7.12%▲
Total equity
17.69%▲
Operating Profit Margin (ROS)
-0.16%▼
Net Profit Margin
-0.15%▼
Return on Equity (ROE)
-15.53%▼
Debt to Equity Ratio
-95.49%▼
Quick Ratio
0.12%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo